Business in Brief: Populism and Legislation Are Pushing Israeli High-tech to Raise Capital Abroad, Says Offical

Teva to sell some of its U.S. generics to the Mayne Pharma Group of Australia; Hadera Paper giving employees options for a 1.84% stake in company; TASE rises, following the lead of overseas exchanges; Shagrir loses 28% in debut.

comments Print
Hauser: Populism and legislation are pushing high-tech to raise capital abroad